CMI
47
-2
TMO
51
4
HCA
48
-2
FFIV
67
-2
AVB
42
-3
ADP
61
-3
AES
31
-9
CNP
36
-8
NUE
50
2
MAS
56
-2
TDC
75
12
BMY
43
-3
SO
51
-6
VZ
34
-3
M
28
-3
O
30
-5
DFS
59
5
LRCX
45
2
BF.B
29
-2
RL
66
-2
CMI
47
-2
TMO
51
4
HCA
48
-2
FFIV
67
-2
AVB
42
-3
ADP
61
-3
AES
31
-9
CNP
36
-8
NUE
50
2
MAS
56
-2
TDC
75
12
BMY
43
-3
SO
51
-6
VZ
34
-3
M
28
-3
O
30
-5
DFS
59
5
LRCX
45
2
BF.B
29
-2
RL
66
-2
Financhill
Back

Amylyx Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
45

AMLX
Amylyx Pharmaceuticals

Last Price:
5.72
Seasonality Move:
6.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Amylyx Pharmaceuticals Price Quote

$5.72
+0.08 (+1.42%)
(Updated: November 4, 2024 at 5:55 PM ET)

Amylyx Pharmaceuticals Key Stats

Sell
45
Amylyx Pharmaceuticals (AMLX) is a Sell
Day range:
$5.41 - $5.80
52-week range:
$1.58 - $19.95
Dividend yield:
0%
P/E ratio:
8.06
P/S ratio:
1.30
P/B ratio:
1.47%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-67.02%
Market cap:
$384M
Revenue:
$380.8M
EPS:
$-2.45

How Much Does Amylyx Pharmaceuticals Make?

Is Amylyx Pharmaceuticals Growing As A Company?

Data Unavailable

Amylyx Pharmaceuticals Stock Price Performance

What Is Amylyx Pharmaceuticals 52-Week High & Low?

Amylyx Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amylyx Pharmaceuticals?

Is Amylyx Pharmaceuticals Cash Flow Positive?

  • What Is AMLX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.7M
  • What Is Amylyx Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.3M
  • What Is Amylyx Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$115.3M

Amylyx Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AMLX return on invested capital is -45.47%
  • What Is Amylyx Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -37.92%
  • What Is AMLX Return On Equity?
    ROE is a measure of profitability and is -45.47%

Amylyx Pharmaceuticals Earnings Date & Stock Price

Amylyx Pharmaceuticals Competitors

Amylyx Pharmaceuticals Dividend Yield

Amylyx Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 23.92%
Revenue: 0% -111.99%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 5.33
Downside from Last Price: -5.44%

Major Shareholders

  • How many AMLX shares are owned by institutional investors?
    62M AMLX shares are owned by institutional investors
  • How many AMLX shares are owned by insiders?
    8.3M AMLX shares are owned by insiders